RNAC CapEx to Revenue
Cartesian Therapeutics Inc · CapEx to Revenue
RNAC CapEx to Revenue
Current (TTM)141.03%retrieved
RNAC CapEx/Revenue (7.47% → 141.03%)
Latest values, visible window
High-resolution chart · PNG
RNAC capex to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 194.9946% | |
| 23.3675% | |
| 0.7922% | |
| 1.0842% | |
| 1.2753% | |
| 4.9105% | |
| 0.7039% | |
| 97.8959% | |
| 354.1063% | |
| 7.2498% | |
| 19.3479% | |
| 7.4671% |